logo
AI Icon𝛼SK or Search
ENTITY

Lexaria Bioscience (LEXX US)

17
Analysis
Health Care • Canada
Lexaria Bioscience Corp improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier ingestion methods. The Company's technology can be applied to ingestible product formats such as foods, beverages, oral suspensions, tablets, and capsules. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio.
more
bullish•Lexaria Bioscience
•08 Sep 2026 23:00•Issuer-paid

LEXX: Introducing DehydraTECH 3.0

Zacks Small-Cap Research Note for Lexaria Bioscience Corp. (LEXX)

Logo
Share
bullish•Lexaria Bioscience
•18 Jul 2026 04:00•Issuer-paid

LEXX: Dosing Started for Animal & Human GLP-1 Studies

Lexaria is a biotechnology company seeking to enhance the bioavailability of multiple drug agents using DehydraTECH (DHT), its technology...

Logo
Share
bullish•Lexaria Bioscience
•15 Jun 2026 22:00•Issuer-paid

LEXX: Animal & Human GLP-1 Studies Continue

Lexaria is a biotechnology company seeking to enhance the bioavailability of multiple drug agents using DehydraTECH (DHT), its technology...

Logo
Share
bullish•Lexaria Bioscience
•24 Feb 2026 09:00•Issuer-paid

LEXX: Final Results from Pilot Study #5

Lexaria is a biotechnology company seeking to enhance the bioavailability of multiple drug agents using DehydraTECH (DHT), its technology using...

Logo
Share
bullish•Lexaria Bioscience
•11 Feb 2026 02:00•Issuer-paid

LEXX: Final Results from Pilot Study #5

Lexaria is a biotechnology company seeking to enhance the bioavailability of multiple drug agents using DehydraTECH (DHT), its technology using...

Logo
Share

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x